BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36989719)

  • 1. Metabolic codependencies in the tumor microenvironment and gastric cancer: Difficulties and opportunities.
    Zhao X; Li K; Chen M; Liu L
    Biomed Pharmacother; 2023 Jun; 162():114601. PubMed ID: 36989719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Codependencies in the Tumor Microenvironment.
    Dey P; Kimmelman AC; DePinho RA
    Cancer Discov; 2021 May; 11(5):1067-1081. PubMed ID: 33504580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer.
    Liu Y; Li C; Lu Y; Liu C; Yang W
    Front Immunol; 2022; 13():1016817. PubMed ID: 36341377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic alterations in the tumor microenvironment and their role in oncogenesis.
    Eisenberg L; Eisenberg-Bord M; Eisenberg-Lerner A; Sagi-Eisenberg R
    Cancer Lett; 2020 Aug; 484():65-71. PubMed ID: 32387442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic crosstalk in the breast cancer microenvironment.
    Dias AS; Almeida CR; Helguero LA; Duarte IF
    Eur J Cancer; 2019 Nov; 121():154-171. PubMed ID: 31581056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metabolic reprogramming on the immune microenvironment in gastric cancer.
    Shang Z; Ma Z; Wu E; Chen X; Tuo B; Li T; Liu X
    Biomed Pharmacother; 2024 Jan; 170():116030. PubMed ID: 38128177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic interactions in cancer: cellular metabolism at the interface between the microenvironment, the cancer cell phenotype and the epigenetic landscape.
    Rinaldi G; Rossi M; Fendt SM
    Wiley Interdiscip Rev Syst Biol Med; 2018 Jan; 10(1):. PubMed ID: 28857478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
    Huang L; Xu H; Peng G
    Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanoresponsive metabolism in cancer cell migration and metastasis.
    Zanotelli MR; Zhang J; Reinhart-King CA
    Cell Metab; 2021 Jul; 33(7):1307-1321. PubMed ID: 33915111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells.
    Yang Y; Huangfu L; Li H; Yang D
    Int J Hyperthermia; 2023; 40(1):2270654. PubMed ID: 37871910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4.
    Martinez-Outschoorn UE; Curry JM; Ko YH; Lin Z; Tuluc M; Cognetti D; Birbe RC; Pribitkin E; Bombonati A; Pestell RG; Howell A; Sotgia F; Lisanti MP
    Cell Cycle; 2013 Aug; 12(16):2580-97. PubMed ID: 23860378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer.
    Zhao L; Liu Y; Zhang S; Wei L; Cheng H; Wang J; Wang J
    Cell Death Dis; 2022 Apr; 13(4):378. PubMed ID: 35444235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor immune-microenvironment in gastric cancer.
    Fang F; Zhang T; Li Q; Chen X; Jiang F; Shen X
    Tumori; 2022 Dec; 108(6):541-551. PubMed ID: 35196917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more.
    Hao X; Ren Y; Feng M; Wang Q; Wang Y
    Biomed Pharmacother; 2021 Sep; 141():111798. PubMed ID: 34120068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.
    Pacella I; Piconese S
    Front Immunol; 2019; 10():1889. PubMed ID: 31507585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.
    Sasidharan Nair V; Saleh R; Toor SM; Cyprian FS; Elkord E
    Cancer Immunol Immunother; 2021 Aug; 70(8):2103-2121. PubMed ID: 33532902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities.
    Ganapathy-Kanniappan S
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):212-220. PubMed ID: 28400131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactic acid promotes macrophage polarization through MCT-HIF1α signaling in gastric cancer.
    Zhang L; Li S
    Exp Cell Res; 2020 Mar; 388(2):111846. PubMed ID: 31945319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tumor metabolic microenvironment on regulatory T cells.
    Wang YA; Li XL; Mo YZ; Fan CM; Tang L; Xiong F; Guo C; Xiang B; Zhou M; Ma J; Huang X; Wu X; Li Y; Li GY; Zeng ZY; Xiong W
    Mol Cancer; 2018 Nov; 17(1):168. PubMed ID: 30477520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.